Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

NCT05077332 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

NCT04575597 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being

NCT04352348 ·Status: UNKNOWN ·Phase: NA

COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose

NCT05392075 ·Status: COMPLETED

Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population

NCT04561102 ·Status: COMPLETED

The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial

NCT05642910 ·Status: UNKNOWN ·Phase: NA

Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19

NCT04590222 ·Status: COMPLETED

Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease

NCT04542967 ·Status: COMPLETED ·Phase: PHASE2

A Simple Approach to Prevent Hospitalization for COVID-19 Patients

NCT04854824 ·Status: COMPLETED

Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized Patients

NCT04354831 ·Status: COMPLETED ·Phase: PHASE2

Host Response Mediators in Coronavirus (COVID-19) Infection

NCT04510623 ·Status: UNKNOWN

The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19

NCT06349655 ·Status: COMPLETED

Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19

NCT04452812 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic

NCT04521088 ·Status: COMPLETED

Real World COVID-19 Antiviral Effectiveness Research

NCT05638919 ·Status: UNKNOWN

Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort

NCT04345991 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Safety and Efficacy of Azvudine and Paxlovid in the Treatment of Hospitalized Patients With COVID-19

NCT05996770 ·Status: NOT_YET_RECRUITING

The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)

NCT04405739 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)

NCT04575584 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

The Efficacy and Safety of Azovudine in the Treatment of COVID-19

NCT05675761 ·Status: UNKNOWN

Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19

NCT04594343 ·Status: COMPLETED ·Phase: PHASE2

An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

NCT05381454 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis

NCT04582331 ·Status: COMPLETED

Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections

NCT04365725 ·Status: COMPLETED

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

NCT04516811 ·Status: TERMINATED ·Phase: PHASE3